Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Cash & Current Investments (2022 - 2025)

CervoMed's Cash & Current Investments history spans 9 years, with the latest figure at $27.3 million for Q3 2025.

  • For Q3 2025, Cash & Current Investments fell 29.86% year-over-year to $27.3 million; the TTM value through Sep 2025 reached $27.3 million, down 29.86%, while the annual FY2024 figure was $38.9 million, 399.46% up from the prior year.
  • Cash & Current Investments for Q3 2025 was $27.3 million at CervoMed, down from $33.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $45.1 million in Q2 2024 and bottomed at $6.4 million in Q1 2024.
  • The 4-year median for Cash & Current Investments is $27.3 million (2025), against an average of $25.3 million.
  • The largest annual shift saw Cash & Current Investments crashed 63.89% in 2024 before it skyrocketed 453.36% in 2025.
  • A 4-year view of Cash & Current Investments shows it stood at $16.5 million in 2022, then crashed by 52.78% to $7.8 million in 2023, then skyrocketed by 399.46% to $38.9 million in 2024, then dropped by 29.87% to $27.3 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Cash & Current Investments are $27.3 million (Q3 2025), $33.5 million (Q2 2025), and $35.2 million (Q1 2025).